Literature DB >> 3177386

Fanconi anemia mutation causes cellular susceptibility to ambient oxygen.

D Schindler1, H Hoehn.   

Abstract

The gene defect causing the Fanconi anemia (FA) phenotype appears to be expressed at the cellular level, since FA fibroblasts show a protracted course of explant outgrowth, a diminished in vitro life span, and very poor cloning. We show that exposure of FA fibroblasts to hypoxic (5% v/v oxygen) culture conditions restores their growth in vitro to near normal. Exposure to elevated oxygen tension (35% v/v) causes accumulations of FA cells in the S and G2/M phases of the cell cycle that are in significant excess of those seen in heterozygote and control strains. In the absence of evidence for defective cytoplasmatic radical scavenging systems, these observations suggest increased nuclear susceptibility to ambient oxygen as cause of the FA cellular phenotype.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3177386      PMCID: PMC1715501     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  27 in total

1.  Regulation of human fibroblast growth rate by both noncycling cell fraction transition probability is shown by growth in 5-bromodeoxyuridine followed by Hoechst 33258 flow cytometry.

Authors:  P S Rabinovitch
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

2.  Abnormal NAD+ levels in cells from patients with Fanconi's anaemia.

Authors:  N A Berger; S J Berger; D M Catino
Journal:  Nature       Date:  1982-09-16       Impact factor: 49.962

3.  The effect of superoxide dismutase, catalase and L-cysteine on spontaneous and on mitomycin C induced chromosomal breakage in Fanconi's anemia and normal fibroblasts as measured by the micronucleus method.

Authors:  A S Raj; J A Heddle
Journal:  Mutat Res       Date:  1980-05       Impact factor: 2.433

4.  The subcellular particulate NADPH-dependent O2.(-)-generating oxidase from human blood monocytes: comparison to the neutrophil system.

Authors:  A N Chaudhry; J T Santinga; T G Gabig
Journal:  Blood       Date:  1982-10       Impact factor: 22.113

5.  The cell cycle of lymphocytes in Fanconi anemia.

Authors:  B Dutrillaux; A Aurias; A M Dutrillaux; D Buriot; M Prieur
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

6.  Thymine glycol and thymidine glycol in human and rat urine: a possible assay for oxidative DNA damage.

Authors:  R Cathcart; E Schwiers; R L Saul; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

7.  Nuclear catalyzed antibiotic free radical formation.

Authors:  N R Bachur; M V Gee; R D Friedman
Journal:  Cancer Res       Date:  1982-03       Impact factor: 12.701

8.  Suppression of cytotoxic effect of mitomycin-C by superoxide dismutase in Fanconi's anemia and dyskeratosis congenita fibroblasts.

Authors:  H Nagasawa; J B Little
Journal:  Carcinogenesis       Date:  1983       Impact factor: 4.944

9.  Specific cellular defects in patients with Fanconi anemia.

Authors:  R Weksberg; M Buchwald; P Sargent; M W Thompson; L Siminovitch
Journal:  J Cell Physiol       Date:  1979-11       Impact factor: 6.384

10.  Investigation of the cell cycle response of normal and Fanconi's anaemia fibroblasts to nitrogen mustard using flow cytometry.

Authors:  S W Dean; M Fox
Journal:  J Cell Sci       Date:  1983-11       Impact factor: 5.285

View more
  27 in total

Review 1.  Molecular pathogenesis of Fanconi anemia.

Authors:  Natalie Collins; Gary M Kupfer
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

Review 2.  Fanconi anemia and the underlying causes of genomic instability.

Authors:  Julie Rageul; Hyungjin Kim
Journal:  Environ Mol Mutagen       Date:  2020-02-06       Impact factor: 3.216

Review 3.  The role of the RB tumour suppressor pathway in oxidative stress responses in the haematopoietic system.

Authors:  Kay F Macleod
Journal:  Nat Rev Cancer       Date:  2008-09-18       Impact factor: 60.716

4.  Fanconi anemia proteins and endogenous stresses.

Authors:  Qishen Pang; Paul R Andreassen
Journal:  Mutat Res       Date:  2009-07-31       Impact factor: 2.433

5.  Partial correction of chromosome instability in Fanconi anemia by desferrioxamine.

Authors:  M Poot; H Hoehn
Journal:  Hum Genet       Date:  1990-05       Impact factor: 4.132

6.  Fanconi Anemia: A Syndrome of Anemia and Skeletal Malformations Progressing to a Gene Network Involved in Genomic Stability and Malignant Disease.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2020-10-22

Review 7.  What is wrong with Fanconi anemia cells?

Authors:  Sharon B Cantor; Robert M Brosh
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  A Rad50-dependent pathway of DNA repair is deficient in Fanconi anemia fibroblasts.

Authors:  Sarah L Donahue; Colin Campbell
Journal:  Nucleic Acids Res       Date:  2004-06-15       Impact factor: 16.971

9.  G2 phase cell cycle disturbance as a manifestation of genetic cell damage.

Authors:  H Seyschab; Y Sun; R Friedl; D Schindler; H Hoehn
Journal:  Hum Genet       Date:  1993-08       Impact factor: 4.132

Review 10.  Oxidative stress in Fanconi anemia hematopoiesis and disease progression.

Authors:  Wei Du; Zsuzsanna Adam; Reena Rani; Xiaoling Zhang; Qishen Pang
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.